We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MARK:QSEAlRayan Bank Analysis

Data as of 2026-03-15 - not real-time

$0.00

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Remark Holdings trades at a microscopic $0.0015 well below its 30‑day simple moving averages (SMA20 ≈ $0.00128, SMA50 ≈ $0.00169) and far beneath the computed DCF fair value of $7.29, suggesting extreme undervaluation. The stock sits near its technical support at $0.001 and faces resistance around $0.02, while the RSI of 50.6 indicates a neutral momentum and the MACD histogram is positive, giving a fleeting bullish signal despite a broader bearish trend. Volume is on a decreasing trajectory and the 30‑day volatility exceeds 530%, highlighting fragile price stability. Fundamentals are weak: negative operating cash flow, operating margin of –11.2%, and a massive max drawdown of –99.5% underscore financial distress. Yet revenue growth is robust at 74.9% and the AI‑driven product portfolio offers a potential long‑run catalyst in a high‑growth technology sector. Investors should weigh the stark price discount against the severe liquidity constraints and operational risks before deciding on exposure.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 3/10

Key Factors

  • Price trading below short‑term SMAs and near support
  • Decreasing volume and high short‑term volatility
  • Negative operating cash flow and widening loss margins

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strong revenue growth (≈75%) despite earnings deficits
  • Large gap between market price and DCF fair value
  • Elevated beta and sector volatility creating price uncertainty

Long Term

> 3 years
Positive
Model confidence: 4/10

Key Factors

  • AI and computer‑vision market tailwinds offering upside potential
  • Substantial undervaluation relative to intrinsic DCF estimate
  • Financial distress and liquidity constraints requiring turnaround

Key Metrics & Analysis

Financial Health

Revenue Growth74.90%
P/E Ratio-0.0
ROA-130.19%
P/B Ratio-0.0
Op. Cash Flow$-8406000
Free Cash Flow$12.7M
Industry P/E33.7

Technical Analysis

TrendBearish
RSI50.6
Support$0.00
Resistance$0.02
MA 20$0.00
MA 50$0.00
MA 200$0.01
MACDBullish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

Fair Value$7.29
GradeUndervalued
TypeGrowth

Risk Assessment

Beta0.87
Volatility533.23%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.